Parse Biosciences. a Seattle biotech startup developing single-cell sequencing products, announced the acquisition of Biomage, a Scotland-based software developer for single-cell RNA data analysis.

New Partnership Brings Innovative Single Cell Solutions to Researchers Across Japan SEATTLE, April 02, 2025--(BUSINESS WIRE)--Parse Biosciences, the leading provider of accessible and scalable ...

Genomics (NASDAQ:TXG) is scheduled to announce Q1 earnings results on Thursday, May 8th, after market close. The consensus ...

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s ...

New Partnership Brings Innovative Single Cell Solutions to Researchers Across Japan SEATTLE — Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today ...